Pharma & Drugs
Share your love
$6.4M Grant for New Dry AMD & Stargardt Treatments
Dr. Christopher Cioffi, the Thomas and Constance D’Ambra Professor in Organic Chemistry at Rensselaer Polytechnic Institute, is collaborating with Dr. Konstantin Petrukhin, Professor of Ophthalmic Science at Columbia University, to develop promising compounds aimed at treating dry age-related macular degeneration…
Promising Drug for Preventing Diabetic Eye and Kidney Disease
New research led by the University of Bristol has identified a promising type of inhibitor drug that could potentially prevent microvascular diabetic complications, including diabetic eye and kidney disease. The study, published in Cardiovascular Diabetology, focuses on protecting the glycocalyx,…
Aviceda’ Kicks off Phase II/III SIGLEC Trial for AMD
Aviceda Therapeutics has initiated the second part of its Phase II/III SIGLEC trial for AVD-104, an ophthalmic candidate aimed at treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The company has dosed the first subject in this phase,…
CDC Investigates Multistate Outbreak Related to Artificial Tears
A recent investigation led by the Centers for Disease Control and Prevention (CDC) has shed light on a multistate outbreak of carbapenemase-producing, carbapenem-resistant Pseudomonas aeruginosa, linked to the use of artificial tears. The details of the investigation were published in…
Foundation Fighting Blindness Launches Gyrate Atrophy Study
The Foundation Fighting Blindness has launched a natural history study targeting gyrate atrophy, a rare and sight-threatening inherited retinal disease. Spearheading this initiative are esteemed researchers Dr. Mandeep S. Singh, MD, PhD, and Dr. David Valle, MD, from the Wilmer…
FDA Clears Eyenuk’s Additional Camera for DR Detection
Eyenuk has received FDA clearance to utilize the Topcon NW400 retinal camera with its EyeArt AI system for automated detection of diabetic retinopathy (DR). This clearance complements the system’s existing clearance for usage with Canon CR-2 AF and Canon CR-2…
Microbial Keratitis (MK) | OBN
Contact lens wearing has been increased globally during recent decades, which is one of the main risk factors for developing microbial keratitis. Microbial keratitis is a severe and dangerous condition that causes cornea inflammation. Potential Complications of Microbial Keratitis It…
FDA Warns of 26 OTC Eye Drops from Several Major Brands|OBN
The FDA has issued a warning not to purchase or use 26 over-the-counter eye drop products due to the potential risk of eye infections that could lead to partial vision loss or blindness. If patients experience signs or symptoms of…
Is Areds 2 Supplement Good for AMD?
AMD stands for age-related macular degeneration and it is an eye disease where your vision is blurred. Using Areds 2 supplement depends on the stage you have the blurry vision either early intermediate or late. Also depending on AMD in…
EVMANN Takes Two Innovative Companies Under its Umbrella
AMSTERDAM, Oct. 5, 2021 /PRNewswire/ — Within framework of global growth strategy implemented in early 2021, VSY Biotechnology GmbH-Germany and Alsanza Medizintechnik und Pharma GmbH-Germany companies which manufacture and sell their innovative products in ophthalmology and orthopedy fields over 90 countries and 6 continents have decided to…